Munich, Germany

Christian Sommerhoff


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Christian Sommerhoff: Innovator in Microprotein Research

Introduction

Christian Sommerhoff is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of microproteins as therapeutic agents. With a total of 3 patents to his name, Sommerhoff's work is paving the way for innovative treatments in medicine.

Latest Patents

Sommerhoff's latest patents focus on the use of microproteins as tryptase inhibitors. These patents disclose various applications of microproteins, especially those forming a cystine knot, for preparing pharmaceutical compositions aimed at treating or preventing diseases linked to tryptase activity. The patents also cover methods for purifying tryptase, using microproteins as carrier molecules, and diagnostic applications for quantifying tryptase in samples. Additionally, his work includes the development of fusion proteins that incorporate inactive barnase, along with nucleic acid molecules encoding these proteins. The research further explores the crystallization of microproteins fused with barnase, providing insights into their structure and potential medical uses.

Career Highlights

Throughout his career, Christian Sommerhoff has worked with various companies, including BioNTech AG. His innovative research has contributed to advancements in the understanding and application of microproteins in therapeutic contexts.

Collaborations

Sommerhoff has collaborated with notable colleagues such as Thomas Bär and Thomas Martin. Their combined expertise has enhanced the research and development of microprotein applications.

Conclusion

Christian Sommerhoff's contributions to the field of microprotein research exemplify the potential of innovative therapies in medicine. His patents and collaborative efforts continue to influence the landscape of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…